Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gracell Biotechnologies Inc ADR
(NQ:
GRCL
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
10.22 (49)
Ask (Size)
10.41 (10)
Prev. Close
10.25
Today's Range
N/A - N/A
52wk Range
2.100 - 10.44
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Gracell Biotechnologies Acquisition Completed
February 22, 2024
From
Gracell Biotechnologies Inc.
Via
GlobeNewswire
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
February 20, 2024
From
Gracell Biotechnologies Inc.
Via
GlobeNewswire
Performance
More News
Read More
Gracell Biotechnologies Inc. (NASDAQ: GRCL) is a Stock Spotlight on 2/7
February 07, 2024
Via
Investor Brand Network
Health Care Company AstraZeneca Announces Acquisition of Gracell Biotechnologies
December 26, 2023
Via
Benzinga
Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets
February 03, 2024
Via
Talk Markets
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
January 29, 2024
From
Gracell Biotechnologies Inc.
Via
GlobeNewswire
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
Via
Benzinga
Exposures
Product Safety
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 16, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
AstraZeneca: Rebound in 2024 with double-digit earnings growth
January 11, 2024
Via
MarketBeat
Exposures
COVID-19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 08, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs
January 05, 2024
Via
Benzinga
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Via
Investor's Business Daily
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
January 04, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
GRACELL BIOTECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Gracell Biotechnologies Inc. - GRCL
December 31, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal
December 31, 2023
Via
Talk Markets
Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review
December 29, 2023
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Investor Sentiment Improves; Dow Jumps Over 150 Points
December 27, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
December 26, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
December 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 26, 2023
Via
Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 26, 2023
Via
Benzinga
Crude Oil Rises Over 3%; US Home Prices Increase In October
December 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 26, 2023
Via
Benzinga
Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket
December 26, 2023
Via
Benzinga
US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs
December 26, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.